Does TPL have the right arguments?

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

gcduck

Rank: President [?]

Points: 12254 [?]

Votes: 135 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Does TPL have the right arguments?

posted on Jul 01, 2008 12:54PM

According to yesterday's alliacense pr, they have:

""We continue to encourage all producers of microprocessor-based products and dependent services to place a high priority on the purchase of an MMP Portfolio License to reduce potential financial exposure,” said Mike Davis, Senior Vice President, Licensing for Alliacense. "

By reading this statement it does not seem a problem for Mr. Davis to argue against the new prior art for the '148 -otherwise every company would first point to the current file from the USPTO and then to the door.

Maybe the Hoya license YESTERDAY was another sedative to calm down shareholders...lol